Popular Keywords

Anaplastic lymphoma kinase

Biological therapies

Biomarkers

Cancer

Chemoradiotherapy

Clinical trials

Aims

The Clinical Lung Cancer is an independent worldwide publisher that publishes disseminating high-quality research and scientific knowledge in the field of Lung Cancer. The journal covers a wide range of topics related to scientific research.

The journal welcomes original research articles, clinical studies, review articles, case reports, and perspectives that contribute to advancing knowledge and understanding in Lung Cancer. It also aims to foster collaboration and exchange of ideas among researchers, clinicians, and other professionals in the field.

Scope

Anaplastic lymphoma kinase

Biological therapies

Biomarkers

Cancer

Chemoradiotherapy

Clinical trials

Comparative effectiveness

Concurrent chemoradiotherapy

Diagnosis and imaging

Epidermal growth factor receptor

Immunotherapy

Lung cancer

Lymph node

Pharmacoeconomics

Progression-free survival

Radiation Pneumonitis

Radiotherapy

Risk and prevention

Squamous cell lung cancer

Surgical approaches

Systemic therapies

Molecular biology of disease

Molecular diagnostics

Multivariate analysis

Overall survival

Journal Info

  • Journal Name: The Clinical Lung Cancer
  • Impact Factor: 1.8
  • ISSN: 3064-6693
  • DOI: 10.52338/tclc
  • Short Name: Tclc
  • Acceptance rate: 55%
  • Volume: 7 (2024)
  • Submission to acceptance: 25 days
  • Acceptance to publication: 10 days
  • Crossref indexed journal
  • Publons indexed journal
  • Pubmed-indexed journal
  • International Scientific Indexing (ISI)-indexed journal
  • Eurasian Scientific Journal Index (ESJI) index journal
  • Semantic Scholar indexed journal
  • Cosmos indexed journal

OUR PUBLICATION BENEFITS

  • International Reach
  • Peer Review
  • Rapid Publication
  • Open Access
  • High Visibility